TeamDrive
RUS

Domain Associates

www.domainvc.com

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2.7 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.  The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 260 life-sciences companies.  The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.

www.dri.com.ru

Domain Russia Investments (DRI) is a company formed by U.S.-based life sciences venture capital firm Domain Associates to help foster innovation in the Russian health sciences sector. DRI plays a crucial role in Domain’s unique strategic collaboration with Rusnano. The collaboration focuses on co-investment into leading US life sciences companies and the eventual production of their innovative healthcare products for the Russian and CIS market.

Media Center

  • 23 November 2017

    Registration of medicines in EAEU will be performed online

    The Eurasian Economic Union (EAEU) is completing the development of a unified information system that will facilitate the registration of medicinal products by businesses in the common market and provide complete information about these drugs to consumers.

  • 23 November 2017

    Kaluga Pharmaceutical Cluster received silver certificate of Cluster Excellence

    In the period of October 24 – 26, 2017, the Association of Kaluga Pharmaceutical Cluster passed the procedure of the on-site audit conducted by the experts of the European Secretariat for Cluster Analysis. The procedure included the evaluation of the cluster management system and core activities  using 30 indicators in accordance with the methodology of the European Cluster Excellence Initiative. The assessment score of the Association of Kaluga Pharmaceutical Cluster performance for more than 70% of these indicators have significantly exceeded the required values. 

  • 22 November 2017

    After unexpected tie, Amsterdam wins ‘coin toss’ for new EMA HQ

    Well, that was unexpected. The EU’s third and final vote on the new location of the European Medicine Agency tied between Milan and Amsterdam, with Amsterdam winning the proverbial coin toss tie-breaker (EU officials drew the city’s name out of a bowl).

  • 22 November 2017

    With only 2 warnings in 2017, pharma's ad police hits historic low

    As the end of the year nears, the pharma industry can usually look back at FDA enforcement letters for insight into the agency's thinking and guidance on marketing communications. But this year, there’s not much to review.

Read more